Can I use a rectal suppository (e.g., mesalamine or budesonide) the day before collecting a fecal calprotectin sample?

Using Rectal Suppositories Before Fecal Calprotectin Testing

You should avoid using rectal suppositories the day before collecting a fecal calprotectin sample, and ideally wait at least 2-3 days after the last suppository use before sample collection.

Rationale for Timing Recommendation

The British Society of Gastroenterology guidelines specifically address fecal calprotectin sample collection and emphasize that practical issues significantly affect test accuracy 1. The guidelines note substantial variability in calprotectin levels related to:

• Different stool samples from the same patient during one day
• Variation related to the interval between stools being passed
• Lack of sample stability at room temperature beyond a few days

The BSG explicitly recommends using the first stool passed in the morning for sampling to minimize these sources of variability 1.

Why Suppositories May Interfere

While the guidelines don't explicitly prohibit suppository use before testing, several factors suggest caution:

• Local rectal inflammation from suppository administration could theoretically cause transient elevation in calprotectin levels unrelated to underlying disease activity
• Suppository residue or vehicle components in the rectum may contaminate the stool sample
• Altered bowel transit from the suppository effect could affect the representativeness of the sample

Evidence on Suppositories and Calprotectin Monitoring

One study specifically examined fecal calprotectin monitoring during mesalamine suppository therapy for rectal inflammation 2. This research demonstrated that calprotectin levels correlate well with disease activity during suppository treatment, but measurements were taken at 8-week intervals during ongoing therapy—not immediately after suppository administration.

The 2023 AGA guideline on biomarkers notes that fecal calprotectin may be less accurate in detecting endoscopic inflammation in patients with ulcerative proctitis or limited segmental disease 3. This is particularly relevant since suppositories are primarily used for proctitis.

Practical Recommendations

For the most accurate fecal calprotectin result:

• Delay sample collection for 2-3 days after the last suppository use if clinically feasible
• Collect the first morning stool when you do sample
• Store the sample for no more than 3 days at room temperature before analysis 1
• Use the same calprotectin assay for serial measurements, as different assays show 2.5- to 5-fold variability 3

Clinical Context Matters

If you need urgent assessment of disease activity and cannot delay testing:

• Consider that a single calprotectin measurement has inherent variability (8-9% within-sample variation at lower levels, up to 18-33% between samples from the same patient) 3
• If results are borderline or unexpected, repeat testing or proceed to endoscopic evaluation for confirmation 3
• Remember that calprotectin thresholds of 50-100 μg/g have the best sensitivity (90.6%) for detecting endoscopically active disease 1

The key principle is that fecal calprotectin is most reliable when collected under standardized conditions, and recent rectal medication administration introduces an uncontrolled variable that could compromise interpretation.